[go: up one dir, main page]

Strange, 2017 - Google Patents

Pathology and drug action in schizophrenia: insights from molecular biology

Strange, 2017

Document ID
16084057627841992006
Author
Strange P
Publication year
Publication venue
Essays in Biochemistry, Volume 33: Molecular Biology of the Brain

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine

Similar Documents

Publication Publication Date Title
Mattson et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Selkoe Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease
US11932908B2 (en) Compositions and methods for diagnosis and treatment of epilepsy
PL185549B1 (en) Genetic se
Oliveras-Salv´ et al. Loss-of-function rodent models for parkin and PINK1
Robertson et al. Schizophrenia: an integrative approach to modelling a complex disorder
Strange Pathology and drug action in schizophrenia: insights from molecular biology
JPH11507821A (en) Methods for identifying therapeutic agents for Alzheimer's disease using transgenic animal models
WO2012144972A2 (en) Methods to inhibit neurodegeneration
JP2000516087A (en) Gene sequences and proteins associated with Alzheimer's disease and uses thereof
US20090100532A1 (en) Transgenic mice expressing hypersensitive nicotinic receptors
Kopnisky et al. Levels of analysis in psychiatric research
Stilley Resveratrol-Inspired Bridged Bicyclic Compounds: Characterizing a Novel Antiepileptic Drug Class
Jadhav The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
Vlug Mechanisms of Neuronal Death in a Transgenic Mouse Model for Amyotrophic Lateral Sclerosis
Tien et al. Open syntaxin overcomes synaptic transmission defects in diverse C. elegans exocytosis mutants
Yamamoto An inducible model of Huntington's disease
Rondão Behavioral and Biochemical Characterization of Stargazin Knock-in Mice Expressing an Intellectual Disability-Linked Mutation
Nasello Mice harboring a Pnkd nonsense mutation associated with tourette disorder have behavioral abnormalities distinct from those observed in Pnkd knockout mice
Friedman Molecular Mechanisms Underlying Striatal Circuitry in Development and Degeneration
Grant Murine embryonal carcinoma (P19) cells as a model system to explore the biology of the amyloid precursor protein
Zike Investigating the Role of Obsessive-Compulsive Disorder Candidate Gene SLC1A1 in Basal Ganglia and Repetitive Behavior
Das Identification and characterization of a novel N-methyl-D-aspartate receptor subunit NR3A
Kendal The Influence of the Deletion and Overexpression of APP in Transgenic Mice on the Morphology of the Dentate Gyrus
Wu Genetic analysis of the GABA synthetic enzymes: from synapse development to activity dependent transcription